Eastern and South-Eastern Asia vs Indonesia: Proportion of the target population who received the final dose of
Eastern and South-Eastern Asia
21.0%
in 2024
Indonesia
79.0%
in 2024
Eastern and South-Eastern Asia rank
26th
Indonesia rank
24th
Proportion of the target population who received the final dose of over time
- Eastern and South-Eastern Asia
- Indonesia
How they compare
Indonesia currently reports 79.0% against 21.0% in Eastern and South-Eastern Asia, a difference of 58.0%.
That makes Indonesia's figure about 3.8 times Eastern and South-Eastern Asia's.
The two have swapped places 1 time across 8 shared years of data; in 2017 it was Eastern and South-Eastern Asia ahead.
Eastern and South-Eastern Asia ranks 26th and Indonesia ranks 24th of 35 groups.
Across the 2 decades both report, Eastern and South-Eastern Asia averaged higher in 1 and Indonesia in 1.
Head to head by decade
| Decade | Eastern and South-Eastern Asia | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.7% | 2.7% | 2.0% | Eastern and South-Eastern Asia |
| 2020s | 8.8% | 24.6% | 15.8% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Eastern and South-Eastern Asia or Indonesia?
- Indonesia, at 79.0% against 21.0% in Eastern and South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Eastern and South-Eastern Asia and Indonesia?
- 58.0%, with Indonesia ahead.
- How many years of comparable data are there for Eastern and South-Eastern Asia and Indonesia?
- 8 years are reported by both, from 2017 to 2024.
- How do Eastern and South-Eastern Asia and Indonesia rank globally for proportion of the target population who received the final dose of?
- Eastern and South-Eastern Asia ranks 26th and Indonesia ranks 24th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.